Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus monotherapy versus tacrolimus plus glucocorticoids in adults with podocytopathies
ChiCTR1800020243Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jan 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Podocytopathies, idiopathic membranous glomerulonephritis (IMG), nephrosis and 1 more comparing Tacrolimus monotherapy with Tacrolimus plus glucocorticoids (2 arms). Primary endpoints: 24-hour urine protein and Serum albumin. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
tacrolimusprednisone
03
Conditions
Podocytopathiesidiopathic membranous glomerulonephritis (IMG)nephrosisfocal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on ChiCTR1800020243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020243.